Trinity Biotech plc (TRIB)
NASDAQ: TRIB · IEX Real-Time Price · USD
1.880
+0.050 (2.73%)
Apr 18, 2024, 3:47 PM EDT - Market closed
Trinity Biotech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 56.83 | 62.52 | 92.97 | 101.98 | 90.44 | 97.04 | 99.14 | 99.61 | 100.2 | 104.87 | Upgrade
|
| Revenue Growth (YoY) | -9.10% | -32.75% | -8.84% | 12.77% | -6.80% | -2.12% | -0.47% | -0.58% | -4.46% | 14.97% | Upgrade
|
| Cost of Revenue | 37.38 | 45.25 | 54.89 | 53.4 | 52.32 | 55.59 | 57.25 | 56.13 | 53.68 | 55.5 | Upgrade
|
| Gross Profit | 19.45 | 17.27 | 38.08 | 48.58 | 38.12 | 41.45 | 41.89 | 43.48 | 46.51 | 49.38 | Upgrade
|
| Selling, General & Admin | 31.15 | 26.98 | 24.68 | 27.5 | 32.7 | 29.48 | 32.25 | 30.37 | 28.23 | 30.07 | Upgrade
|
| Research & Development | 4.38 | 4.14 | 4.5 | 5.08 | 5.33 | 5.37 | 5.66 | 5.04 | 5.07 | 4.29 | Upgrade
|
| Other Operating Expenses | 10.96 | 5.5 | 2.27 | 15.92 | 24.2 | 26.83 | 41.66 | 47.93 | -0.29 | -0.42 | Upgrade
|
| Operating Expenses | 46.5 | 36.62 | 31.45 | 48.5 | 62.23 | 61.68 | 79.56 | 83.33 | 33.01 | 33.94 | Upgrade
|
| Operating Income | -27.05 | -19.35 | 6.63 | 0.08 | -24.11 | -20.23 | -37.67 | -39.85 | 13.51 | 15.44 | Upgrade
|
| Interest Expense / Income | 11.05 | 24.73 | 7.1 | 6.75 | 6.58 | 5.08 | 5.41 | 5.44 | 4.05 | 0.13 | Upgrade
|
| Other Expense / Income | -14.02 | -2.88 | -1.17 | 0.34 | -0.77 | -2.69 | -1.59 | 58.9 | -13.1 | -2.39 | Upgrade
|
| Pretax Income | -24.08 | -41.2 | 0.7 | -7.01 | -29.92 | -22.62 | -41.48 | -104.18 | 22.55 | 17.69 | Upgrade
|
| Income Tax | -0.06 | -0.19 | -0.18 | -0.62 | -1.01 | -0.53 | -1.21 | -3.56 | 0.76 | 0.48 | Upgrade
|
| Net Income | -24.02 | -41.01 | 0.88 | -6.39 | -28.91 | -22.09 | -40.27 | -100.63 | 21.8 | 17.21 | Upgrade
|
| Net Income Growth | - | - | - | - | - | - | - | - | 26.62% | 78.46% | Upgrade
|
| Shares Outstanding (Basic) | 152 | 84 | 84 | 84 | 96 | 96 | 96 | 96 | 94 | 92 | Upgrade
|
| Shares Change | 82.32% | - | - | -13.06% | - | - | 0.34% | 1.62% | 2.18% | 3.71% | Upgrade
|
| EPS (Basic) | - | -6.00 | 0.20 | -1.60 | -7.00 | -5.20 | -9.40 | -22.00 | 4.80 | 3.80 | Upgrade
|
| EPS (Diluted) | - | -6.00 | 0.20 | -1.60 | -7.00 | -5.20 | -9.40 | -22.00 | 2.40 | 3.60 | Upgrade
|
| EPS Growth | - | - | - | - | - | - | - | - | -33.33% | 80.00% | Upgrade
|
| Free Cash Flow | - | -6.89 | 2.94 | 14.47 | -6.44 | -10.16 | -5.82 | -10.54 | -13.43 | -11.7 | Upgrade
|
| Free Cash Flow Per Share | - | -1.65 | 0.70 | 3.46 | -1.34 | -2.11 | -1.21 | -2.20 | -2.85 | -2.54 | Upgrade
|
| Dividend Per Share | - | - | - | - | - | - | - | - | 1.100 | 1.100 | Upgrade
|
| Dividend Growth | - | - | - | - | - | - | - | - | 0% | 10.00% | Upgrade
|
| Gross Margin | 34.22% | 27.62% | 40.96% | 47.64% | 42.15% | 42.72% | 42.25% | 43.65% | 46.42% | 47.08% | Upgrade
|
| Operating Margin | -47.59% | -30.95% | 7.13% | 0.08% | -26.66% | -20.85% | -37.99% | -40.00% | 13.48% | 14.72% | Upgrade
|
| Profit Margin | -42.26% | -65.59% | 0.94% | -6.26% | -31.97% | -22.76% | -40.62% | -101.02% | 21.75% | 16.41% | Upgrade
|
| Free Cash Flow Margin | - | -11.01% | 3.16% | 14.19% | -7.12% | -10.47% | -5.87% | -10.58% | -13.40% | -11.15% | Upgrade
|
| Effective Tax Rate | - | - | -25.54% | - | - | - | - | - | 3.35% | 2.71% | Upgrade
|
| EBITDA | - | -14.14 | 10.54 | 2.82 | -18.44 | -13.41 | -30.88 | -92.61 | 32.25 | 22.32 | Upgrade
|
| EBITDA Margin | - | -22.61% | 11.34% | 2.77% | -20.39% | -13.82% | -31.15% | -92.97% | 32.19% | 21.28% | Upgrade
|
| Depreciation & Amortization | - | 2.33 | 2.74 | 3.08 | 4.89 | 4.12 | 5.2 | 6.13 | 5.64 | 4.5 | Upgrade
|
| EBIT | -13.02 | -16.47 | 7.79 | -0.26 | -23.34 | -17.54 | -36.08 | -98.74 | 26.61 | 17.83 | Upgrade
|
| EBIT Margin | -22.92% | -26.34% | 8.38% | -0.25% | -25.81% | -18.07% | -36.39% | -99.13% | 26.55% | 17.00% | Upgrade
|